Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
grade D 1.28 1.59% 0.02
VBLT closed up 1.59 percent on Friday, September 13, 2019, on 27 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical VBLT trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Support Bullish 1.59%
Above Upper BB Strength 1.59%

Older signals for VBLT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Medicine Biotechnology Health Biopharmaceutical Cancer Medical Specialties Pharmaceutical Industry Autoimmune Diseases Clinical Trial Ovarian Cancer Psoriasis Ulcerative Colitis Treatment Of Ovarian Cancer Brain Cancer Recurrent Glioblastoma Thyroid Cancer
Is VBLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.9
52 Week Low 0.6
Average Volume 32,413
200-Day Moving Average 1.2914
50-Day Moving Average 1.2525
20-Day Moving Average 1.1843
10-Day Moving Average 1.209
Average True Range 0.0548
ADX 17.97
+DI 21.0224
-DI 13.7404
Chandelier Exit (Long, 3 ATRs ) 1.1756
Chandelier Exit (Short, 3 ATRs ) 1.2644
Upper Bollinger Band 1.2703
Lower Bollinger Band 1.0983
Percent B (%b) 1.06
BandWidth 14.523347
MACD Line 0.0039
MACD Signal Line -0.0136
MACD Histogram 0.0175
Fundamentals Value
Market Cap 34.57 Million
Num Shares 27 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -1.91
Price-to-Sales 0.00
Price-to-Book 4.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.30
Resistance 3 (R3) 1.29 1.29 1.29
Resistance 2 (R2) 1.29 1.28 1.29 1.29
Resistance 1 (R1) 1.28 1.28 1.29 1.29 1.29
Pivot Point 1.28 1.28 1.28 1.28 1.28
Support 1 (S1) 1.27 1.27 1.28 1.28 1.27
Support 2 (S2) 1.27 1.27 1.27 1.27
Support 3 (S3) 1.26 1.27 1.27
Support 4 (S4) 1.27